These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21669864)

  • 1. Short- to mid-term results using autologous bone-marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Johnson JD; Pin RH; Parks AM; Hankins T; Hartman JF; Wright ML
    Vasc Endovascular Surg; 2011 Jul; 45(5):398-406. PubMed ID: 21669864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
    Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
    Van Tongeren RB; Hamming JF; Fibbe WE; Van Weel V; Frerichs SJ; Stiggelbout AM; Van Bockel JH; Lindeman JH
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):51-8. PubMed ID: 18212687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
    Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
    J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials.
    Wen Y; Meng L; Gao Q
    Expert Opin Biol Ther; 2011 Dec; 11(12):1581-9. PubMed ID: 21973046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
    Gabr H; Hedayet A; Imam U; Nasser M
    Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of lower extremity wounds in patients with peripheral arterial disease: a stratified conservative approach.
    Chiriano J; Bianchi C; Teruya TH; Mills B; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2010 Nov; 24(8):1110-6. PubMed ID: 21035703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
    Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
    Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter.
    Yongquan G; Lianrui G; Lixing Q; Xuefeng L; Zhu T; Shijun C; Yingfeng W; Jianming G; Jian Z; Zhonggao W
    Int Angiol; 2013 Aug; 32(4):362-7. PubMed ID: 23822938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
    Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
    J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
    Amann B; Luedemann C; Ratei R; Schmidt-Lucke JA
    Cell Transplant; 2009; 18(3):371-80. PubMed ID: 19500466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
    Rigato M; Monami M; Fadini GP
    Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    van Haelst STW; Teraa M; Moll FL; de Borst GJ; Verhaar MC; Conte MS
    J Vasc Surg; 2018 Oct; 68(4):1104-1113.e1. PubMed ID: 29802042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.
    Yusoff FM; Kajikawa M; Matsui S; Hashimoto H; Kishimoto S; Maruhashi T; Chowdhury M; Noma K; Nakashima A; Kihara Y; Sueda T; Higashi Y
    Sci Rep; 2019 May; 9(1):7711. PubMed ID: 31118440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder].
    Boda Z; Udvardy M; Farkas K; Tóth J; Jámbor L; Soltész P; Rázsó K; Oláh Z; Ilonczai P; Szarvas M; Litauszky K; Hunyadi J; Sipos T; Kappelmayer J; Veréb Z; Rajnavölgyi E
    Orv Hetil; 2008 Mar; 149(12):531-40. PubMed ID: 18343769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.